Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushenqiangjin is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Guangdong Second Traditional Chinese Medicine Hospital, primarily administered in capsule form. It is designed based on the TCM therapeutic principle of tonifying the kidney and strengthening the sinews and bones. The drug is primarily indicated for patients with knee osteoarthritis, particularly to aid recovery and improve joint function, muscle strength, and blood circulation following total knee replacement (TKR) surgery. Clinical research, such as trial ChiCTR2000034337, has focused on its ability to enhance postoperative rehabilitation outcomes and modulate muscle and blood parameters in patients undergoing orthopedic procedures.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushenqiangjin.